NYSE:BHC (Bausch Health Companies)
About
Last updated Jan 20, 2021, 04:00:00pm ESTRelated Articles
Valeant Pharmaceuticals Shares Jump on Rumoured Deal
Iain Butler | May 24, 2013
This company is going to pull off a massive deal one way or the other. More »
Valeant, Capstone Higher But For Opposite Reasons
Iain Butler | April 29, 2013
One company is a serial acquirer that faces a busted deal. The other just transformed the company in one fell swoop. Investors... More »
Valeant Wins Obagi
Iain Butler | April 8, 2013
Ring up another "win" for Valeant! More »
Serialously ā Another Acquisition for Valeant
Iain Butler | March 21, 2013
This serial acquirer is sticking with its strategy. The company's sizeable debt burden makes this a risky proposition. More »
Smoke Today, Fire Tomorrow?
Iain Butler | March 7, 2013
One of the things that can ruin a company is financial risk. Valeant Pharmaceuticals is loaded with it and nobody seems to care. More »